Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Reisinger, AC; Fandler-Höfler, S; Kreuzer, P; Toth-Gayor, G; Schmidt, A; Gary, T; Rief, P; Eller, P; Brodmann, M.
VA-ECMO and thrombus aspiration in a pulmonary embolism patient with cardiac arrest and contraindications to thrombolytic therapy.
Vasa. 2022; 51(5):315-319 Doi: 10.1024/0301-1526/a001019 (- Case Report)
PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Brodmann Marianne
Reisinger Alexander Christian
Co-Autor*innen der Med Uni Graz
Eller Philipp
Fandler-Höfler Simon
Gary Thomas
Rief Peter
Schmidt Albrecht
Toth-Gayor Gabor

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

A 57-year-old male patient with a history of proximal deep vein thrombosis on vitamin K antagonist therapy, suffered a recent hypertensive intracranial hemorrhage without significant neurological deficit. Three weeks later he presented with bilateral central pulmonary embolism. He had witnessed cardiac arrest and was put on veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Endovascular thrombectomy with an Aspirex device led to a significant improvement of hemodynamics. VA-ECMO was terminated after one day, an IVC filter was inserted, and he was discharged from ICU after 15 days. In conclusion, VA-ECMO and endovascular therapy are rescue strategies in patients with contraindications for thrombolysis.
Find related publications in this database (using NLM MeSH Indexing)
Contraindications - administration & dosage
Extracorporeal Membrane Oxygenation - administration & dosage
Heart Arrest - diagnosis, etiology, therapy
Humans - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Pulmonary Embolism - complications, diagnostic imaging, therapy
Thrombolytic Therapy - adverse effects
Thrombosis - administration & dosage